Carl Zeiss Acquires Bio-Rad's Cell Science Division
By Biotechdaily staff writers
Posted on 15 Jun 2004
In a move that will enlarge its microscopy business, Carl Zeiss (Oberkochen, Germany) has acquired the Cell Science Division (Hemel Hempstead, UK) of Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Terms were not disclosed.Posted on 15 Jun 2004
This strategic move is part of the ongoing investment in enhancing the application expertise at Carl Zeiss, according to the company. The acquisition is expected to accelerate future advances in confocal and multiphoton microscope instrumentation with Carl Zeiss as the major driving force in the field.
"Today, Carl Zeiss stands for high-end laser scanning microscopes that are benchmark solutions for advanced applications in 3-D microscopy,” said Dr. Ulrich Simon, head of the microscopy business group at Carl Zeiss. "Joining our forces will strengthen our relationship with Zeiss and Bio-Rad customers, and will allow a considerable additional refinement of both companies' worldwide service and support network.”
Related Links:
Carl Zeiss
Bio-Rad
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
